Free Trial

Autonomix Medical Q4 2023 Earnings Report

Autonomix Medical logo
$2.98 -0.49 (-14.12%)
As of 04:00 PM Eastern

Autonomix Medical EPS Results

Actual EPS
-$4.60
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Autonomix Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Autonomix Medical Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Autonomix Medical Earnings Headlines

Autonomix granted U.S. patent for catheter-based technology
⭕ [URGENT] Buy Alert just triggered
This opportunity is killer. The smart money is already buying up shares in this company keeping the AI boom alive.
See More Autonomix Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Autonomix Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Autonomix Medical and other key companies, straight to your email.

About Autonomix Medical

Autonomix Medical (NASDAQ:AMIX), a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

View Autonomix Medical Profile

More Earnings Resources from MarketBeat